Telehealth General Psychiatry Prescribing: What Psychiatric NPs Can Do

If you’re a psychiatrist or psychiatric nurse practitioner trying to navigate prescribing regulations—especially via telehealth—you’ve probably googled some version of ‘can psychiatrists prescribe medication remotely’ or ‘what medications can a PMHNP prescribe vs an MD?’ You’re not alone. The rules are confusing, state-specific, and constantly evolving.

Let’s cut through the confusion. Yes, psychiatrists can prescribe medication—all psychiatric medications, including controlled substances like Adderall, Xanax, and Suboxone. And yes, you can do this via telehealth in 2026, thanks to federal waivers and state telehealth laws. But the details matter, especially if you’re a psychiatric nurse practitioner or practicing across state lines.

This guide covers what you need to know: psychiatrist vs PMHNP prescribing authority, state-by-state telehealth rules, controlled substance regulations, reimbursement for medication management, and how these rules affect your practice—whether you’re in California, Texas, Florida, New York, Pennsylvania, or Illinois.

What Psychiatrists Can Prescribe (And Why It’s Different From PMHNPs)

Psychiatrists (MD/DO) have full, unrestricted prescribing authority in all 50 states. If you have a medical license and DEA registration, you can prescribe any psychiatric medication—SSRIs, antipsychotics, mood stabilizers, benzodiazepines, stimulants, buprenorphine, you name it. No collaboration required. No formulary restrictions. No physician supervisor checking your work.

Psychiatric Mental Health Nurse Practitioners (PMHNPs), on the other hand, face a patchwork of state rules. About half of U.S. states now grant nurse practitioners Full Practice Authority (FPA), meaning they can evaluate, diagnose, and prescribe independently—just like psychiatrists. The other half require some form of physician collaboration or supervision, which can range from a formal written agreement to ongoing chart reviews and prescriptive authority limits.

Here’s the breakdown by state practice model:

Full Practice Authority States (FPA)

In these states, experienced PMHNPs can practice independently—no physician oversight, no collaborative agreement. They can prescribe controlled substances under their own DEA registration. As of 2025, approximately 34 states have Full Practice Authority for NPs. Recent additions include Massachusetts (2021), Kansas (2022), Indiana (2023), Louisiana (2024), and Michigan (2025).

Key FPA states among our priorities:

• Washington, Oregon, Arizona, New Mexico, Colorado, Minnesota have been FPA states for years.
• New York grants FPA after 3,600 hours of supervised practice (roughly 2 years full-time).
• California is transitioning: experienced NPs can become ‘103 NPs’ (semi-independent in group settings as of 2023) and ‘104 NPs’ (fully independent by January 2026).
• Illinois allows FPA after 4,000 hours of collaboration plus 250 hours of continuing education.

Reduced Practice States

PMHNPs have independence for some functions but need a collaborative practice agreement (CPA) with a physician for prescribing. These agreements outline scope, require periodic chart reviews, and often mandate physician availability for consultation.

Examples:

• Pennsylvania: NPs must maintain a collaborative agreement indefinitely. No pathway to independence yet, though legislation has been proposed.
• New York (for new NPs): Requires written protocols and physician collaboration for the first 3,600 hours, then transitions to FPA.

Restricted Practice States

NPs must practice under continuous physician supervision or delegation. All prescribing is delegated from a physician, and the NP cannot practice independently—ever.

Examples:

• Texas: NPs must have a Prescriptive Authority Agreement with a physician to prescribe any medication. No independent prescribing. Texas law also restricts NPs from prescribing Schedule II controlled substances in outpatient settings (with narrow exceptions for terminal illness or pediatric ADHD under specific conditions). One physician can supervise a maximum of 7 NPs/PAs.
• Florida: Psychiatric NPs were excluded from the state’s 2020 autonomous practice law, which only applies to primary care NPs. PMHNPs still need physician collaboration. However, Florida law does allow ‘psychiatric nurses’ (PMHNPs with 2+ years experience under a psychiatrist) to prescribe psychotropic controlled substances for mental health treatment—a carve-out not available to other NP specialties.

What This Means for Your Practice

If you’re a psychiatrist, these rules don’t affect you directly—but they do affect your ability to collaborate with or supervise NPs. In restricted states like Texas and Florida, many PMHNPs work under psychiatrists or for telehealth companies that provide physician oversight as part of the business model.

If you’re a PMHNP, your prescribing authority depends entirely on where your patient is located. Practicing telehealth across multiple states means navigating different collaborative agreement requirements, formulary restrictions, and supervision rules. Some states require the collaborating physician to be a psychiatrist (Florida for psychotropics, for example). Others cap the number of NPs a physician can supervise (Texas: 7 max). These administrative hurdles are real—and they affect how quickly you can start seeing patients and what medications you can prescribe.

Free consultations available with select providers only.

Grow your practice on Klarity

Free to list. Pay only for new patient bookings. Most providers see their first patient within 24 hours.

Start seeing patients

Free to list. Pay only for new patient bookings. Most providers see their first patient within 24 hours.

Telehealth Prescribing: What’s Allowed in 2026?

Telehealth has become mainstream in psychiatry, and the regulatory landscape has mostly caught up. As of February 2026, psychiatrists and PMHNPs can prescribe psychiatric medications—including controlled substances—via telehealth in most states, thanks to federal flexibilities and state telehealth laws.

Federal Rules: The DEA’s Ryan Haight Waiver Extension

Normally, the Ryan Haight Act requires an in-person medical evaluation before prescribing controlled substances. But since the COVID-19 public health emergency, the DEA has waived this requirement for telemedicine. That waiver remains in effect through December 31, 2025, allowing providers to prescribe Schedule II–V controlled substances to new patients via telehealth without an initial in-person visit.

What does this mean practically? You can:

• Start a new ADHD patient on Adderall after a video evaluation
• Prescribe Xanax for anxiety via telemedicine
• Initiate buprenorphine (Suboxone) for opioid use disorder remotely

The DEA has proposed permanent rules that would impose some new requirements (like a special telemedicine registration or limits on 30-day supplies), but as of early 2026, those haven’t been finalized. Until they are, the current flexibilities remain. Stay alert for DEA announcements in late 2024 and 2025—these rules could tighten.

State Telehealth Laws: The Details That Matter

Even with federal flexibility, you must follow your state’s telehealth prescribing laws. Here’s where things get interesting—some states have explicitly permitted teleprescribing of controlled substances for psychiatric treatment, while others have additional restrictions.

Florida: Explicit Permission for Psychiatric Controlled Substances

Florida law (F.S. 456.47) explicitly allows controlled substances to be prescribed via telehealth for the treatment of psychiatric disorders. This is a carve-out: Florida generally restricts telehealth prescribing of opioids for chronic pain (requires in-person exam), but mental health treatment is exempt. So a Florida-licensed psychiatrist can prescribe stimulants, benzodiazepines, or other psychiatric meds to a Florida patient via video visit—no in-person requirement.

For PMHNPs in Florida, there’s an extra wrinkle: while the law allows psychiatric nurses to prescribe psychotropic controlled substances for mental illness, they must be practicing under a psychiatrist’s protocol and meet the definition of ‘psychiatric nurse’ (PMHNP with 2+ years experience under a psychiatrist).

Texas: Mental Health Exception (But No Chronic Pain)

Texas permits telemedicine prescribing if the standard of care is met and the evaluation is sufficient (real-time audio-video). For controlled substances, Texas defaults to federal law but prohibits prescribing opioids for chronic pain via telehealth—you must see those patients in person. Mental health treatment is different: Texas allows teleprescribing of controlled substances for conditions like ADHD or acute anxiety under the federal waiver.

Texas also mandates checking the state Prescription Monitoring Program (PMP) before prescribing any controlled substance, telehealth or in-person. For PMHNPs in Texas, remember you need a Prescriptive Authority Agreement with a physician, and Schedule II prescribing is generally restricted to very narrow situations (terminal illness, emergency, or pediatric ADHD under delegation).

New York: State Law Aligned With Federal Flexibility

In mid-2025, New York finalized regulations removing state obstacles to controlled substance prescribing via telehealth. The rule now says: an in-person exam is required by default, except when federal law (the DEA waiver) allows telemedicine. This means NY psychiatrists can continue teleprescribing under the current DEA waiver without state-level non-compliance.

New York’s rule also enumerates exceptions similar to the DEA’s proposed regulations—like if another practitioner performed an in-person exam within 12 months, or for short-term emergency prescriptions. Importantly, it adds a catch-all: providers can rely on any allowances provided by federal law. Translation: as long as the DEA waiver is active, you’re good to go.

One Medicare wrinkle: starting in 2025, Medicare patients receiving tele-mental health services must have an in-person visit at least once every 6–12 months (the exact frequency has been debated). This is a billing rule, not a state law, but plan for occasional in-person check-ins for Medicare compliance if you’re seeing NY patients exclusively online.

California: Telehealth Exam Counts as ‘Good Faith Exam’

California law requires a ‘good faith exam’ before prescribing, but it explicitly permits this exam to be done via telehealth. A 2023 bill (AB 1503) further clarified that a video exam satisfies the standard for prescribing, including controlled substances. California defers to federal law on controlled substances, so during the DEA waiver period, CA psychiatrists have been prescribing stimulants and other controlled meds to new patients via telemedicine.

California does require enrollment in CURES (the state’s PMP) and checking it before prescribing Schedule II–IV drugs—at least once every 4 months for ongoing therapy. This applies equally to telehealth practice.

Pennsylvania and Illinois: Following Federal Lead

Both states have no unique telehealth prescribing restrictions beyond federal law. Providers must follow the Ryan Haight Act (currently waived), but the states themselves don’t ban controlled substance teleprescribing. Pennsylvania’s Medicaid and major insurers cover telepsychiatry; Illinois has strong telehealth parity (more on that below).

Establishing a Valid Patient-Physician Relationship

All states require a legitimate clinical relationship before prescribing. Telehealth counts as a valid encounter in nearly every state, as long as it meets the standard of care. Most states require real-time audio-visual interaction—a phone call alone generally isn’t enough for an initial evaluation when prescribing controlled substances (though some states allow audio-only follow-ups for established patients).

Best practices:

• Use a HIPAA-compliant video platform
• Verify patient identity and location
• Conduct a thorough history and mental status exam
• Document the encounter with the same detail as an in-person visit
• Have an emergency protocol if the patient is in crisis (especially important for telepsychiatry)

Prescribing Across State Lines

You must be licensed in the state where the patient is physically located at the time of the consult. The Interstate Medical Licensure Compact (IMLC) helps expedite licenses in member states. Among our priority states, Texas, Pennsylvania, and Illinois are IMLC members. New York, Florida, and California are not, so you’ll need to go through the traditional licensure process.

Some states offer special telehealth registrations for out-of-state providers, but these often come with restrictions. For example, Florida has an out-of-state telehealth registration, but providers using it cannot prescribe controlled substances—so most telepsychiatrists opt for full Florida licensure instead.

Reimbursement for Medication Management: What to Expect

Understanding how medication management visits are billed and paid is crucial for practice sustainability. The good news: telehealth parity has arrived for mental health in most states, and psychiatry is one of the better-reimbursed specialties in medicine.

Common CPT Codes for Psychiatric Med Management

Initial evaluations:

• 90792 (Psychiatric Diagnostic Evaluation with Medical Services): 60-minute initial consult. Medicare pays approximately $173 in 2026.

Follow-up medication checks (E/M codes):

• 99213 (15-minute, moderate complexity): Medicare pays $92–$96 in 2026
• 99214 (25-minute, moderate to high complexity): Medicare pays $125–$136 in 2026
• 99215 (40-minute, high complexity): Medicare pays $192 in 2026 (rarely used for routine med checks)

If you’re doing therapy + med management in the same visit, you can bill the E/M code plus a psychotherapy add-on code (90833 for 30 min, 90836 for 45 min). Medicare pays roughly $80–$135 extra for these add-ons.

Medicare vs Private Insurance vs Medicaid

Medicare rates (2026 national average):

• Medicare pays NPs at 85% of physician rates when billed under the NP’s own NPI. So a PMHNP billing 99213 gets ~$80 vs the psychiatrist’s ~$95.
• ‘Incident to’ billing (where an NP’s service is billed under a supervising physician) can pay 100%, but this doesn’t apply to telehealth under current Medicare rules.

Private insurance:

• Commercial payers often pay more than Medicare. In high-cost areas, a psychiatrist might get $150 for a 99213 and $200 for a 99214 from Blue Cross or United.
• About 43 states have telehealth parity laws requiring insurers to cover telehealth the same as in-person. For behavioral health specifically, over half of those states mandate payment parity—meaning no reduction in reimbursement just because it was a video visit.

State parity examples:

• Illinois: SB 667 (2021) mandates equal reimbursement for telehealth through at least 2027
• California: AB 744 (2019) requires payment parity for telehealth for contracts after 2021
• Texas: Has telehealth coverage law but doesn’t mandate payment parity. However, most Texas insurers voluntarily pay equal rates for tele-mental health due to high demand.

Medicaid:

• Rates tend to be lower than Medicare or commercial (e.g., Florida Medicaid might pay $60–$80 for a 15-min med check).
• Many states have enhanced Medicaid behavioral health reimbursement recently. New York Medicaid reimburses tele-mental health at the same rate as face-to-face.
• Some states cover audio-only telehealth for mental health (important for patients without video access). Medicare covers audio-only mental health services through at least 2024, paying the same rate as video for certain visits.

Collaborative Care Model (CoCM) Codes

If you’re serving as a psychiatric consultant to primary care teams, you can bill Collaborative Care Model codes:

• 99492: First month of CoCM, Medicare pays ~$161
• 99493: Subsequent months, Medicare pays ~$130

This is a monthly fee for psychiatric oversight—not a per-visit code. Some states’ Medicaid (New York, Washington) also reimburse CoCM.

The Economics of Telehealth Psychiatry

Let’s talk real numbers. A psychiatrist doing 15-minute med checks can see 4 patients per hour. At Medicare’s $95 per 99213, that’s $380/hour in gross revenue. With good scheduling and telehealth’s lower no-show rates, many telepsychiatrists see 20–25 patients per day at sustainable pace.

Private pay rates are higher—some telepsychiatry platforms charge patients $100–$200 per visit for ADHD medication management. But accepting insurance opens access to a larger patient base and steady referral flow.

What about patient acquisition costs? This is where traditional marketing falls apart for most providers. Let’s be blunt about the real economics:

The Real Cost of DIY Patient Acquisition

If you’re building your own practice, acquiring a qualified psychiatric patient through DIY marketing typically costs $200–$500+ when you factor in ALL costs:

• SEO investment: Takes 6–12 months of consistent investment before generating meaningful patient flow. Most solo providers don’t have the expertise or patience for this.
• Google Ads: Mental health keywords cost $15–$40+ per click. Most clicks don’t convert to booked patients. A realistic cost per booked patient through PPC is $200–$400+.
• Directory listings (Psychology Today, Zocdoc): Monthly subscription fees ($30–$100) PLUS you compete with hundreds of other providers on the same page. Zocdoc charges $35–$100 per booking, and total monthly costs add up fast.
• Agency/consultant fees: If you hire help, add thousands more per month
• Staff time: Someone has to handle and qualify leads, follow up on no-shows, manage ad campaigns
• Testing and optimization: Failed campaigns, seasonal fluctuations, competition changes
• No-show rates: Cold leads from ads often have 30–40% no-show rates

Bottom line: Most providers spend $3,000–$5,000/month on marketing with uncertain results. That’s the gamble.

The Platform Economics Alternative

This is where a pay-per-appointment model makes sense. Instead of gambling $4,000/month on marketing, you pay a standard listing fee only when a qualified patient books with you.

The value proposition:

• No upfront marketing spend or monthly subscription fees—you only pay when you see patients
• Pre-qualified patients already matched to your specialty and availability
• No wasted ad spend on clicks that don’t convert
• Built-in telehealth infrastructure—no separate EHR or video platform costs
• Both insurance and cash-pay patient flow—diversified revenue streams
• You control your schedule—set your own hours and case types

Instead of spending $60,000/year on marketing with uncertain ROI, you pay only when a patient shows up. That’s guaranteed ROI vs gambling on marketing channels that may or may not work.

Could you eventually build cost-effective marketing yourself? Sure—if you have the budget, expertise, and patience to invest 12+ months in SEO, test and optimize PPC campaigns, manage directory profiles, and handle lead qualification. For most providers—especially those starting out or scaling quickly—that’s not realistic. A platform that handles patient acquisition removes the risk entirely.

State-Specific Guide: Where You Can Practice and What Rules Apply

Let’s break down the six priority states: California, Texas, Florida, New York, Pennsylvania, and Illinois. Each has unique rules affecting both psychiatrists and PMHNPs.

California

Psychiatrists: Full independent prescribing. Telehealth prescribing allowed with ‘good faith exam’ (video qualifies). Must check CURES (PMP) before prescribing Schedule II–IV.

PMHNPs: Transitioning to independence via AB 890 (2020). As of 2023, NPs with ≥3 years experience can become ‘103 NPs’ and practice in group settings without physician supervision. By January 2026, they can become ‘104 NPs’ with full independent practice (including solo practice and prescribing). New NPs still need physician-supervised standardized procedures for first 3 years.

Telehealth: Private payers must cover telehealth at parity. California permits video exams to satisfy prescribing requirements.

Market demand: California has 11+ million people in mental health shortage areas. Psychiatrist-to-population ratio is ~1:5,000–5,800 statewide, but rural areas are severely underserved.

Texas

Psychiatrists: Full independent prescribing. Can prescribe controlled substances via telehealth for mental health (but NOT for chronic pain—that requires in-person). Must check Texas PMP before prescribing controlled substances.

PMHNPs: Restricted practice. Must have Prescriptive Authority Agreement with a physician for ANY prescribing. No independent prescribing pathway. NPs generally cannot prescribe Schedule II controlled substances in outpatient settings (narrow exceptions for pediatric ADHD or terminal illness). One physician can supervise max 7 NPs/PAs. Monthly face-to-face meetings required for first 3 years of collaboration, then quarterly.

Telehealth: Texas permits telemedicine prescribing if standard of care is met. No payment parity mandate (insurers can negotiate rates), but most voluntarily pay equal rates for mental health.

Market demand: One of the worst psychiatrist shortages in the nation. Ratio of 1:8,500–9,000 residents. 380 mental health shortage areas needing 614 psychiatrists.

Florida

Psychiatrists: Full independent prescribing. Florida law explicitly allows teleprescribing of controlled substances for psychiatric treatment (but not for chronic pain). Must check Florida’s E-FORCSE (PMP).

PMHNPs: Restricted for psychiatric specialty. Florida’s 2020 autonomous practice law excluded psych NPs—only primary care NPs can practice independently. PMHNPs must practice under physician protocol. ‘Psychiatric nurses’ (PMHNPs with 2+ years under a psychiatrist) can prescribe psychotropic controlled substances for mental illness in collaboration with a psychiatrist. Schedule II prescriptions for non-psych NPs are limited to 7 days; psych NPs are exempt from this limit for mental health treatment.

Telehealth: Strong telehealth statute allowing controlled substance prescribing for psychiatric disorders. Out-of-state providers can register for telehealth but cannot prescribe controlled substances under that registration (need full license).

Market demand: Severe shortage. Ratio of 1:8,500+ residents. ~7.8 million Floridians in mental health shortage areas.

New York

Psychiatrists: Full independent prescribing. New York finalized 2025 regulations aligning state controlled-substance prescribing with federal telehealth allowances. Can prescribe via telehealth under DEA waiver. Must check NY’s PMP (I-STOP). E-prescribing required for all controlled substances (no paper scripts).

PMHNPs: Reduced practice transitioning to FPA. New NPs must practice under written collaborative agreement for first 3,600 hours (~2 years). After that, they can practice independently without written agreement—only need attestation of ‘collaborative relationship’ with physicians (informal consultation, no supervision). Experienced NPs essentially have full practice authority.

Telehealth: All insurers must cover telehealth. Strong telehealth support with payment parity for mental health. Audio-only mental health services covered by many payers.

Market demand: High concentration of psychiatrists in NYC (~1:2,900 statewide), but upstate is severely underserved. ~197 mental health shortage areas needing ~230 psychiatrists.

Pennsylvania

Psychiatrists: Full independent prescribing. No unique telehealth restrictions beyond federal law. Can prescribe controlled substances via telehealth under DEA waiver.

PMHNPs: Reduced practice (no FPA). Must have collaborative agreement with physician indefinitely (no pathway to independence yet, though legislation has been proposed). Physician must review portion of NP charts regularly. Can prescribe Schedule II–V if collaborating physician delegates it; Schedule II prescriptions limited to 30-day supply and physician must be notified within 24 hours.

Telehealth: Pennsylvania Medicaid and major insurers cover telepsychiatry. No comprehensive state telehealth parity law yet (efforts ongoing).

Market demand: Mid-ranked provider density (1:4,586 residents), with rural central PA most underserved. ~65 psychiatrist vacancies to eliminate shortage areas.

Illinois

Psychiatrists: Full independent prescribing. No telehealth prescribing restrictions beyond federal law. Can prescribe controlled substances via telehealth under DEA waiver.

PMHNPs: Reduced practice with pathway to FPA. Must have Written Collaborative Agreement for 4,000 hours + 250 CE hours in advanced pharmacology. After meeting requirements, can apply for Full Practice Authority APRN license, allowing independent practice and prescribing (including controlled substances). Until FPA granted, prescriptions must list collaborating physician’s name.

Telehealth: Illinois requires private insurers to reimburse telehealth at parity through 2027 for behavioral health (SB 667). Strong telehealth support. Illinois also permits specially trained clinical psychologists to prescribe limited mental health meds under psychiatrist supervision.

Market demand: ~291 practitioners needed to eliminate mental health shortages. Rural Illinois and some urban underserved areas most affected.

Collaborative Agreements: What PMHNPs Need to Know

If you’re a PMHNP in a restricted or reduced practice state, your collaborative practice agreement (CPA) is the legal foundation of your prescribing authority. Here’s what these typically include:

Scope Definition

• Lists authorized duties and prescriptive authority
• May exclude certain drug classes (e.g., some states restrict NP prescribing of chemotherapy or contrast agents—not relevant in psych)
• Can be more restrictive than state law (e.g., collaborating physician might limit NP to adults only, or exclude ADHD stimulants for children)

Physician Availability

• Specifies how physician is available for consultation (phone, email, etc.)
• Response time requirements
• Backup coverage when physician is unavailable

Chart Review Requirements

• South Carolina: MD must review at least 10% of NP charts monthly
• Tennessee: Periodic on-site visits required
• Texas: Quality assurance meetings with case review (often interpreted as 10% monthly chart review)
• Pennsylvania: Physician must countersign portion of charts, especially for Schedule II prescriptions

Prescription Limitations

• Some states require physician to explicitly delegate controlled substance prescribing in the agreement
• Florida: Controlled substance prescribing by NP must be explicitly delegated; psychiatric NPs must have psychiatrist collaborator for psychotropics
• Texas: Agreement must include plan for supervision and specify which medications NP can prescribe
• Pennsylvania: Collaborating physician for psych NP should be psychiatrist or physician with mental health expertise

Filing and Compliance

• Some states require filing CPA with state board (e.g., Kentucky requires filing ‘CAPA-CS’ for controlled substances)
• Agreements must be updated if collaborating physician changes or NP adds practice sites
• Missed filings or outdated protocols can jeopardize licensure

Cost consideration: Many physicians charge a fee to serve as collaborator ($1,000–$5,000+ annually, depending on state requirements and review intensity). This affects NP income and is part of the economic calculation when choosing where to practice.

Practical Takeaways: What This Means for Your Practice

For Psychiatrists

You have maximum flexibility. You can:

• Practice telehealth in any state where you’re licensed
• Prescribe all psychiatric medications, including controlled substances, via video visits
• Supervise or collaborate with PMHNPs where required (and potentially earn collaboration fees)
• Bill at full Medicare rates (not 85% like NPs)

Key compliance points:

• Stay licensed in every state where patients are located
• Check state PMPs before prescribing controlled substances
• Follow telehealth consent and documentation requirements
• Monitor DEA rule changes for controlled substance prescribing (expected late 2024/2025)

For PMHNPs

Your authority depends entirely on state law. In FPA states (or after reaching FPA in transitional states), you practice just like a psychiatrist. In restricted states, you need:

• A collaborating physician (often a psychiatrist for psych NPs)
• A written collaborative practice agreement
• Regular chart reviews and meetings
• Explicit delegation for controlled substance prescribing

Strategic considerations:

• If you’re early in your career in a restricted state, consider working for a telehealth platform or group practice that provides physician oversight as part of the business model
• If you have experience and want independence, consider getting licensed in FPA states where you can practice without a collaborator
• Budget for collaboration fees ($1,000–$5,000+ annually) in states requiring physician oversight

For Both: The Platform Advantage

Whether you’re a psychiatrist or PMHNP, building your own practice means taking on:

• Marketing costs ($3,000–$5,000/month with uncertain ROI)
• Patient acquisition risk (6–12 months before SEO pays off; PPC costs $200–$400+ per booked patient)
• Administrative overhead (credentialing, billing, EHR, telehealth platform)
• Compliance management (staying current on 50 different state laws)

A telehealth platform like Klarity Health handles all of this:

• Pre-qualified patient flow (no wasted marketing spend)
• Pay-per-appointment model (only pay when you see patients)
• Built-in infrastructure (telehealth platform, credentialing support, billing)
• Multi-state compliance (platform tracks state requirements)
• Flexible scheduling (set your own hours and case types)

For PMHNPs in restricted states, platforms can provide the required physician oversight as part of the service—no need to find and pay for your own collaborating physician.

What’s Next: Staying Ahead of Regulatory Changes

The regulatory landscape is evolving rapidly:

Federal:

• DEA permanent rules on telemedicine controlled substance prescribing expected by late 2024/early 2025
• Medicare telehealth flexibilities for mental health likely to be extended or made permanent
• Possible new requirements (special telemedicine registration, 30-day supply limits)

State:

• More states moving toward NP Full Practice Authority (several bills pending in 2024–2025)
• Telehealth parity laws becoming permanent in many states
• Interstate licensure compacts expanding (IMLC for physicians, APRN Compact for NPs)

How to stay current:

• Monitor your state medical/nursing board websites for rule updates
• Subscribe to professional association newsletters (APA, AAPP, AANP, state chapters)
• Check DEA announcements at deadiversion.usdoj.gov
• Follow policy trackers like the Center for Connected Health Policy (cchpca.org)

Or join a platform that tracks this for you. One of the hidden values of working with an established telehealth network is that they monitor regulatory changes across all states and update provider requirements accordingly. You focus on patient care; they handle compliance.

Frequently Asked Questions

Can psychiatrists prescribe controlled substances via telehealth in 2026?

Yes. Under current DEA waivers (extended through December 31, 2025), psychiatrists can prescribe Schedule II–V controlled substances to new patients via telehealth without an initial in-person visit. This includes stimulants (Adderall, Ritalin), benzodiazepines (Xanax, Klonopin), and buprenorphine (Suboxone). State laws vary—some states like Florida explicitly allow this for psychiatric treatment; others like Texas permit it for mental health but not chronic pain. Watch for DEA permanent rule changes expected in late 2024/2025.

What’s the difference between a psychiatrist and a PMHNP when it comes to prescribing?

Psychiatrists have full, unrestricted prescribing authority in all 50 states—no collaboration required. PMHNPs’ authority depends on state law: about half of states grant Full Practice Authority (independent prescribing after meeting experience requirements), while the other half require physician collaboration or supervision. In restricted states like Texas and Florida, PMHNPs must practice under a physician’s oversight and may have formulary restrictions (e.g., limited Schedule II prescribing).

Can a PMHNP prescribe Adderall or Xanax independently?

It depends on the state. In Full Practice Authority states (like Washington, Oregon, New York after 3,600 hours, California by 2026 for experienced NPs, Illinois after FPA certification), yes—PMHNPs can prescribe these independently under their own DEA registration. In restricted states (Texas, Florida for psych NPs, Pennsylvania), they need physician collaboration and explicit delegation in their collaborative agreement. Some states (like Texas) prohibit outpatient NP prescribing of Schedule II stimulants except in narrow circumstances.

Do I need separate licenses to practice telepsychiatry in multiple states?

Yes. You must be licensed in the state where your patient is physically located during the consultation. The Interstate Medical Licensure Compact (IMLC) helps physicians get licenses in multiple member states more efficiently (Texas, Pennsylvania, and Illinois are members among our priority states). The APRN Compact does the same for NPs, but compact licensure does not override state scope-of-practice laws—a Texas NP still needs physician collaboration even with a compact license.

How much does Medicare pay for a psychiatric medication management visit via telehealth?

For 2026, Medicare pays approximately $95 for a 15-minute follow-up (CPT 99213) and $136 for a 25-minute follow-up (CPT 99214). Initial psychiatric evaluations with medication management (CPT 90792) pay around $173. These are the same rates as in-person visits—Medicare has telehealth payment parity for mental health. PMHNPs billing under their own NPI receive 85% of these amounts ($80 for 99213, $115 for 99214).

What are the best states for PMHNPs to practice independently?

States with Full Practice Authority and no transition period include Washington, Oregon, Arizona, New Mexico, Colorado, and Minnesota. Among our priority states, New York (after 3,600 hours), California (by 2026 for experienced NPs), and Illinois (after 4,000 hours + CE) offer pathways to independence. Pennsylvania still requires indefinite collaboration. Texas and Florida are restricted for psych NPs

Source:

• https://www.bon.texas.gov/faqpracticeaprn.asp.html#:~:text=certificate%20or%20fetal%20death%20certificate,For%20additional%20information
• https://www.npschools.com/blog/guide-to-np-practice-in-florida#:~:text=match%20at%20L200%20%E2%80%9CUnder%20HB,%E2%80%9D
• https://natlawreview.com/article/telehealth-and-person-visits-tracking-federal-and-state-updates-pandemic-era#:~:text=In%20late%202024%2C%20the%20U,prescribing
• https://www.flsenate.gov/laws/statutes/2024/464.012#:~:text=,the%20treatment%20of%20mental%20disorders
• https://www.cchpca.org/texas/#:~:text=including%2C%20but%20not%20limited%20to%2C,Code%2C%20Chapters%20481%20and%20483
• https://www.cchpca.org/texas/#:~:text=,way%20communication
• https://www.nursepractitioneronline.com/articles/nurse-practitioner-practice-authority-updates/#:~:text=As%20of%202025%2C%20the%20distribution,toward%20greater%20autonomy%20for%20NPs
• https://www.nursepractitioneronline.com/articles/nurse-practitioner-practice-authority-updates/#:~:text=,Michigan%20%282025
• https://www.pacnp.org/general/custom.asp?page=ScopeofPractice#:~:text=tests%2C%20and%20deliver%20other%20health,appropriate%20experience%20can%20receive%20a
• https://www.jdsupra.com/legalnews/new-law-allows-experienced-nps-to-8292796/#:~:text=New%20York%E2%80%99s%202023%20state%20budget%2C,practice%20without%20a%20collaborative%20relationship